Its primary stakeholders are Nephrology, Endocrinology, Cardiology, Neurology and General Medicine. Once fully established and operational, intention is to also include Nursing, Allied Health, Respiratory Medicine, Rheumatology and potentially mental health. The research direction and outcomes that will emanate from the WHCDA have direct synergy and are complimentary to the objectives and aims of the Healthlinks project.

The research undertaken by the WHCDA encompasses and has applicability to a broad range of clinical services provided by WH and is not limited by age, gender or ethnicity. Our initial focus is on early detection and proper management of chronic vascular disease as manifested by obesity, smoking, dietary and lifestyle factors and familial hyperlipidaemia and their ensuing disease states such as chronic kidney disease, diabetes, heart disease peripheral vascular disease and stroke.   This is done in partnership with our nursing and allied health departments, academic partners, national peak bodies (Primary Healthcare Network, Stroke foundation, Kidney Health Australia and Heart Foundation) and primary healthcar e providers.  The CD-IMPACT project is our primary research example in this space. The WH Healthlinks program research evaluation is also considered a priority project within this space.